LapSpace Medical

Company Overview

Snapshot

Founded in December 2011, LapSpace Medical operated with 1–10 employees. The company raised $1 million across one funding round from two investors. In October 2014, LapSpace Medical rolled out its novel surgical device in the US market.

Business overview

LapSpace Medical developed an inflatable balloon retractor designed for laparoscopic procedures. This device, deployed through a standard trocar, inflates within the abdominal cavity to gently retract organs, creating a stable operating field. The retractor's self-retaining clamp allows for extended use without additional surgical personnel, aiming to improve efficiency and reduce surgery costs. The company served the healthcare industry, focusing on hospitals and surgical centers with its medical devices for gastroenterology and gynecology.

Strategic signal

In October 2014, LapSpace Medical launched its novel surgical device in the United States. This expansion into a major healthcare market signaled the company's readiness for broader commercialization and indicated a validation of its technology for laparoscopic procedures, positioning it for potential growth within the medical device sector.

Company Intelligence Q&A

What is LapSpace Medical's primary product?

LapSpace Medical developed an inflatable balloon retractor designed for laparoscopic procedures, which provides efficient organ retraction to create a stable operating field.

When did LapSpace Medical cease operations?

LapSpace Medical ceased to operate in September 2020.

When did LapSpace Medical launch its surgical device in the US?

In October 2014, LapSpace Medical rolled out its novel surgical device in the US market.

What was LapSpace Medical's last disclosed funding round?

In November 2013, LapSpace Medical raised $1 million from The Trendlines Group and Office of the Chief Scientist.

What markets did LapSpace Medical target?

LapSpace Medical targeted the European and United States markets with its medical devices.